Literature DB >> 12914399

[Optimal recurrence prevention of iodine deficiency related goiter after thyroid gland operation. A prospective clinical study].

P M Schumm-Draeger1, A Encke, K H Usadel.   

Abstract

In summary the data of our study show: (1) Sonographically determined thyroid volume of patients with euthyroidism after surgery is found to be significantly lower with a combination therapy (iodide 150 microgram +Levothyroxine 75 microgram) compared to patients with iodide monotherapy (200 microgram). (2) Thyroid volume of patients with hypothyroidism after surgery is found to be significantly lower during a combination therapy (150 microgram iodide + 75 microgram L-thyroxine) compared to patients with a Levothyroxine monotherapy. (3) Patients with hypothyroidism and Levothyroxine monotherapy, however present with a significant increase of thyroid volume after surgery. (4) Urinary iodide excretion in the treatment groups with iodide or combination therapy increases significantly during therapy, however, patients with Levothyroxine monotherapy do not show changes. (5) Thyroid function is well stabilized in all treatment groups with adequate controls and adjustment of Levothyoxine dosage. There data clearly demonstrate that the combination therapy with Levothyoxine and iodide significantly improves prophylaxis of goiter recurrence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914399     DOI: 10.1007/s00108-003-0879-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  9 in total

1.  Treatment of juvenile goitre with levothyroxine, iodide or a combination of both: the value of ultrasound grey-scale analysis.

Authors:  D Einenkel; K H Bauch; G Benker
Journal:  Acta Endocrinol (Copenh)       Date:  1992-10

2.  Clinical, laboratory and immunologic effects of the treatment of endemic goiter with T4, T3 and KI.

Authors:  D A Koutras; G D Piperingos; D Pallas; K Katsouyanni; K S Karaiskos; P Marafelia; D Makriyannis; J Kitsopanides; J Sfontouris; J Mantzos
Journal:  Thyroidology       Date:  1990-08

3.  [Combination therapy of endemic goiter with two different thyroxine/iodine combinations].

Authors:  B Klemenz; G Förster; H Wieler; G Kahaly; K P Kaiser; C Hansen; P Willkomm; J Ruhlmann
Journal:  Nuklearmedizin       Date:  1998-05       Impact factor: 1.379

4.  [Therapy of euthyroid iron deficiency goiter. Effectiveness of a combination of L-thyroxine and 150 micrograms iodine in comparison with mono-L-thyroxine].

Authors:  M Grussendorf
Journal:  Med Klin (Munich)       Date:  1996-08-15

5.  [Comparison of the effectiveness of two different dosages of levothyroxine-iodide combinations for the therapy of euthyroid diffuse goiter].

Authors:  M Kreissl; M Tiemann; H Hänscheid; J Rendl; C Reiners
Journal:  Dtsch Med Wochenschr       Date:  2001-03-02       Impact factor: 0.628

6.  [Therapy of iodine deficiency goiter in adolescents with iodine or a combination of iodine and levothyroxine with special reference to lipid parameters].

Authors:  G Rönnefarth; E Kauf; F Deschner; M Forberger
Journal:  Klin Padiatr       Date:  1996 May-Jun       Impact factor: 1.349

7.  Treatment of iodine deficiency goiter with iodine, levothyroxine or a combination of both.

Authors:  G Hintze; J Köbberling
Journal:  Thyroidology       Date:  1992-04

8.  [Individually dosed levothyroxine with 150 micrograms iodide versus 100 micrograms levothyroxine combined with 100 micrograms iodide. A randomized double-blind trial].

Authors:  G Förster; F Krummenauer; C Hansen; J Beyer; G Kahaly
Journal:  Dtsch Med Wochenschr       Date:  1998-05-29       Impact factor: 0.628

9.  A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects.

Authors:  D Glinoer; P De Nayer; F Delange; M Lemone; V Toppet; M Spehl; J P Grün; J Kinthaert; B Lejeune
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

  9 in total
  1 in total

Review 1.  [Surgical resection of the thyroid and parathyroid glands].

Authors:  U Woenckhaus; R Büttner; L C Bollheimer
Journal:  Internist (Berl)       Date:  2007-06       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.